News In Reviews: Google Inc. (NASDAQ:GOOG), CACI International Inc. (NYSE:CACI), Ritter Pharmaceuticals Inc (NASDAQ:RTTR)

Google Inc. (NASDAQ:GOOG) slightly dropped on Wednesday as the firm reported that it an employee of Google Inc. died in an accident at the Cannes Lions festival in France. Google wouldn’t comment on reports that the employee was an executive in its U.K. team who was engaged in a car accident, and the company said it wasn’t releasing further details in respect of family privacy. Google said in an e-mailed statement, “We lost a loved and respected member of our team.” The Cannes Lions in France is the largest annual gathering of advertising and marketing executives. Shares of Google Inc. (NASDAQ:GOOG) opened at $540 with 680.92 million outstanding shares and hit to its highest price of $540 during the day and finally closed at $537.84 by scoring -0.49%. In the whole session, it traded on volume of 1.29 Million shares, which turned higher than its average volume.

A provider of information solutions, CACI International Inc. (NYSE:CACI) released that it’s provided outlook for the fiscal year 2016, anticipating earnings of $5.24 to $5.65 a share on revenues of $3.3B to $3.5B. Analysts polled by Thomson Reuters predict the firm to report earnings of $5.57 a share on revenues of $3.43B for 2016. Analysts’ estimations typically exclude special items. The company’s chief executive officer, Ken Asbury stated that their focus on delivering larger, higher-end solutions will drive organic revenue and net income growth for FY16 and the long term. The company reiterated its guidance for 2015, estimating earnings of $5.12 to $5.33 a share on revenues of $3.3 billion to $3.35 billion. CACI International Inc. (NYSE:CACI) stock price closed at $85.14 with the total traded volume of 132211 shares. Its price to sales ratio ended at 0.61. Its market capitalization is 2.06 Billion. The stock owned by the Financial Institutions was 93 % while by insiders was 0.30%.

Ritter Pharmaceuticals Inc (NASDAQ:RTTR) released that pricing of its IPO of 4M shares of its common stock at a price to the public of $5 a share. Ritter Pharmaceuticals, Inc. is offering all of the common stock. The gross proceeds to Ritter Pharmaceuticals, Inc. from the IPO anticipated being $20M before deducting underwriting discounts and commissions and other estimation offering costs. Ritter has granted the underwriters a 45-day option to purchase around 600,000 additional shares of common stock to cover over-allotments, if any. The common stock of Ritter Pharmaceuticals, Inc. has been approved for listing on The NASDAQ Capital Market and is expected to begin trading under the ticker symbol “RTTR” on June 24, 2015. The offering is expected to close on June 29, 2015, subject to customary closing conditions. Ritter Pharmaceuticals Inc (NASDAQ:RTTR) begun last trade with a price of $5  and throughout the trading session climbed at a high of $5.50.